Northwest Biotherapeutics | NWBO - Ordinary Share Capital


Northwest Biotherapeutics reported $1.14M in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
Agenus USD 266K 30K Mar/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celldex Therapeutics USD 66.45M 53K Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Merck USD 2.49B 15.79M Sep/2025
Northwest Biotherapeutics USD 1.14M 30K Sep/2023
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025